Neurology and mental health

Carbidopa

antiparkinsonian

Nothing to add

By the Layer Nutrition editorial team · How the atlas classifies the 664 molecules

What this medicine is for

Carbidopa is a medicine in the "antiparkinsonian" category. This medicine corrects the dopamine deficit of Parkinson's disease to improve movement.

For Carbidopa in practice: Combined with levodopa to enhance its antiparkinsonian effect. It is generally taken over the long term, within regular monitoring, and is not stopped on your own initiative.

Under which brands it is found

Carbidopa is part of about 13 presentations listed in France. It is available under various trade names and as generics.

Duodopa
Lecigimon
Levodopa Carbidopa Teva
Levodopa Carbidopa Teva Lp
Levodopa/Carbidopa/Entacapone Arrow
Levodopa/Carbidopa/Entacapone Biogaran
Levodopa/Carbidopa/Entacapone Teva
Levodopa/Carbidopa/Entacapone Viatris
and other presentations

Generics and the original brand are equivalent for the active substance; only the appearance, the name or the excipients may differ.

Do you need a supplement? No.

For Carbidopa, we offer no supplement. No nutritional supplementation has any serious justification to set against this treatment, and we prefer to say so rather than invent a need. Our range is limited to five classes of everyday medicines for which a targeted intake makes sense; beyond these, we sell nothing for the sake of selling, and that is what gives weight to our five references.

Related molecules

To explore in the « Neurology and mind » family and its neighbours.

RopiniroleantiparkinsonianNothing to add LevodopaantiparkinsonianNothing to add RasagilineantiparkinsonianNothing to add PramipexoleantiparkinsonianNothing to add EntacaponeantiparkinsonianNothing to add CabergolineantiparkinsonianNothing to add

See the whole « Neurology and mind » family · Back to the atlas

Explore the atlas Explore the range